Yeah, RCE is a serial offender of bending the truth! It's why...

Yeah, RCE is a serial offender of bending the truth! It's why I'm invested to be honest, sheer entertainment value.

But take the phrase "clinical subject". It's technically correct, the subjects are in a 'clinical trial'. But it would generally mean "subjects that have a clinical condition". i.e, a urinary tract infection, in this case. But why use the phrase at all?!

Here's another howler:
"Data from this trial is expected to pave the way for a Phase II UTI/Urosepsis efficacy trial, potentially establishing R327 as a frontline treatment."
Complete nonsense. What does "establish as a frontline treatment" mean?! Surely only a phase 3 can establish anything as a frontline treatment.

Who writes like this?! No scientist or doctor, surely. No one that has any experience at all in biotech. So I'm not sure Recce's board really is reviewing and approving these announcements. There is just too much marketing word-salad.

Is it actionable by ASX? I dunno. They lack a suitable amount of truthiness in my opinion, and it's often the information that they DON'T release which is more serious.